文献速递生殖医学产科

程序化与自然周期玻璃化复苏囊胚移植的母儿结局比较

Maternal and perinatal outcomes in programmed versus natural vitrified-warmed blastocyst transfer cycles.
PubMed 文献 · Reprod Biomed Online · 2020-03-21

该回顾性队列研究纳入2013至2018年间在大学附属生殖中心接受程序化或自然周期冻融囊胚移植并获单胎活产的775例患者。程序化FET组总体母体并发症、妊娠期高血压疾病、未足月胎膜早破及剖宫产率均高于自然周期组,校正混杂后妊娠期高血压疾病调整OR为2.39(95%CI 1.37至4.17)。围产儿结局两组无显著差异。

要点

  • 程序化FET组总体母体并发症32.2%(126/391),高于自然周期组18.8%(72/384),P<0.01。
  • 程序化FET组妊娠期高血压疾病15.3%(60/391),高于自然周期组6.3%(24/384),P<0.01;调整OR 2.39(95%CI 1.37至4.17)。
  • 两组围产儿结局无显著差异,包括出生体重(3357.9±671.6 g vs 3318.4±616.2 g,P=0.40)和出生缺陷率(1.5% vs 2.1%,P=0.57)。

核心结论

  • 程序化周期玻璃化复苏囊胚移植的妊娠期高血压疾病发生概率约为自然周期移植的两倍。
  • 作者建议将所有符合条件的FET患者首选自然周期FET以降低妊娠期高血压疾病风险。

研究设计与样本

  • 大学附属生殖中心的回顾性队列研究,纳入2013至2018年间接受程序化或自然周期FET并获单胎活产的775例患者,使用玻璃化冻融囊胚。
  • 共分析384例自然周期和391例程序化周期单胎妊娠。

主要发现

  • 程序化FET组总体母体并发症32.2%(126/391)vs 自然周期组18.8%(72/384),P<0.01。
  • 程序化FET组妊娠期高血压疾病15.3%(60/391)vs 自然周期组6.3%(24/384),P<0.01。
  • 程序化FET组未足月胎膜早破2.6%(10/391)vs 自然周期组0.3%(1/384),P=0.02。
  • 程序化FET组剖宫产53.2%(206/387)vs 自然周期组42.8%(163/381),P=0.03。
  • 两组出生体重分别为3357.9±671.6 g vs 3318.4±616.2 g(P=0.40),出生缺陷率分别为1.5%(6/391)vs 2.1%(8/384)(P=0.57),均无显著差异。

关键数值与推荐

  • 校正年龄、体质指数、产次、吸烟状态、糖尿病或慢性高血压史、不孕诊断、移植胚胎数及胚胎植入前遗传学检测使用后,程序化vs自然周期FET的妊娠期高血压疾病调整OR为2.39(95%CI 1.37至4.17)。
  • 校正上述混杂因素后,程序化vs自然周期FET的总体母体并发症调整OR为2.21(95%CI 1.51至3.22)。

临床怎么用

  • 作者建议将所有符合条件的FET患者首选自然周期FET以降低妊娠期高血压疾病风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Do maternal and perinatal outcomes differ between natural and programmed frozen embryo transfer (FET) cycles? DESIGN: Retrospective cohort study at a university-affiliated fertility centre including 775 patients who underwent programmed or natural FET cycles resulting in a singleton live birth using blastocysts vitrified between 2013 and 2018. RESULTS: A total of 384 natural and 391 programmed FET singleton pregnancies were analysed. Programmed FET resulted in higher overall maternal complications (32.2% [126/391] versus 18.8% [72/384]; P < 0.01), including higher probability of hypertensive disorders of pregnancy (HDP) (15.3% [60/391] versus 6.3% [24/384]; P < 0.01), preterm premature rupture of membranes (2.6% [10/391] versus 0.3% [1/384]; P = 0.02) and caesarean delivery (53.2% [206/387] versus 42.8% [163/381]; P = 0.03) compared with natural FET. After controlling for potential confounders, including age, body mass index, parity, smoking status, history of diabetes or chronic hypertension, infertility diagnosis, number of embryos transferred and use of preimplantation genetic testing, the adjusted odds ratio for HDP was 2.39 (95% CI 1.37 to 4.17) and for overall maternal complications was 2.21 (95% CI 1.51 to 3.22) comparing programmed with natural FET groups. The groups did not significantly differ for any perinatal outcomes analysed, including birth weight (3357.9 ± 671.6 g versus 3318.4 ± 616.2 g; P = 0.40) or rate of birth defects (1.5% [6/391] versus 2.1% [8/384]; P = 0.57), respectively. CONCLUSION: Vitrified-warmed blastocyst transfer in a programmed cycle resulted in a twofold higher probability of HDP compared with transfer in a natural cycle. Natural FET cycle should, therefore, be recommended as first line for all eligible patients undergoing FET to reduce the risk of HDP.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Makhijani R, Bartels C, Godiwala P, et al. Maternal and perinatal outcomes in programmed versus natural vitrified-warmed blastocyst transfer cycles. Reprod Biomed Online. 2020. PMID: 32505542. doi:10.1016/j.rbmo.2020.03.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。